QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists, and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it expects fiscal third quarter 2008 net sales to grow approximately 14% from the year ago period to approximately $40.7 million. The fiscal third quarter sales increase would represent the largest quarterly year over year sales increase in fiscal 2008.
